Reshape Biotech - About the company
Reshape Biotech is a series A company based in Kongens Lyngby (Denmark), founded in 2018 by Magnus Madsen, Carl-Emil Grøn and Daniel Storgaard. It operates as a Provider of scalable robotic platform. Reshape Biotech has raised $29.2M in funding from investors like Y Combinator, ACME and Astanor. The company has 37 active competitors, including 11 funded and 7 that have exited. Its top competitors include companies like Automata, Opentrons and Transcriptic.
Company Details
Provider of scalable robotic platform. It provides automated imaging and incubation capabilities, designed for data-driven decision making in microbiology research and development labs. Its also designed to simplify routine tasks, freeing up scientists to focus on more complex research and collaboration.
- Website
- reshapebiotech.com
- Email ID
- *****@reshapebiotech.com
- Phone Number
- +45 **********
Key Metrics
Founded Year
2018
Location
Kongens Lyngby, Denmark
Stage
Series A
Total Funding
$29.2M in 4 rounds
Latest Funding Round
Investors
Ranked
5th among 37 active competitors
Employee Count
64 as on May 31, 2026
Legal entities associated with Reshape Biotech
Reshape Biotech is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Reshape ApS CIN: 40056173 , Denmark, Active | - | 32 (As on Mar 31, 2024) |
Sign up to download Reshape Biotech's company profile
Reshape Biotech's funding and investors
Reshape Biotech has raised a total funding of $29.2M over 4 rounds. Its first funding round was on 2021. Its latest funding round was a Series A round on Apr 09, 2024 for $*****. 6 investors participated in its latest round. Reshape Biotech has 8 institutional investors and 3 angel investors.
Here is the list of recent funding rounds of Reshape Biotech:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 09, 2024 | 8050839 | Series A | 4978302 | 1967162 | 6304346 | 3565243 |
Feb 09, 2023 | 9581313 | Seed | 8493578 | 1198964 | 7303588 | |
May 23, 2021 | 2120068 | Seed | 2445330 | 8679622 | 9890451 |
View details of Reshape Biotech's funding rounds and investors
Reshape Biotech's founders and board of directors
Founder? Claim ProfileThe founders of Reshape Biotech are Magnus Madsen, Carl-Emil Grøn and Daniel Storgaard. Carl-Emil Grøn is the CEO of Reshape Biotech.
Here are the details of Reshape Biotech's key team members:
- Magnus Madsen: Co-founder and Chief Revenue Officer of Reshape Biotech.
- Carl-Emil Grøn: CEO & Co-founder of Reshape Biotech.
- Daniel Storgaard: Co-Founder of Reshape Biotech. Contact Info: 1 email address
View details of Reshape Biotech's Founder profiles and Board Members
Reshape Biotech's employee count trend
Reshape Biotech has 64 employees as of May 26. Here is Reshape Biotech's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Reshape Biotech's Competitors and alternates
Top competitors of Reshape Biotech include Automata, Opentrons and Transcriptic. Here is the list of Top 10 competitors of Reshape Biotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Automata 2015, London (United Kingdom), Series C | Developer of modular lab automation platforms for biological research workflows | $177M | 67/100 | |
2nd | Opentrons 2013, Brooklyn (United States), Series C | Developer of pipetting robot for lab automation | $261M | 61/100 | |
3rd | Transcriptic 2012, Menlo Park (United States), Series A | Provider of a cloud-based remote robotic bio-lab | $27.7M | 54/100 | |
4th | Medra 2021, San Francisco (United States), Series A | Developer of robots to automate repetitive wet lab tasks | $63M | 49/100 | |
5th | Reshape Biotech 2018, Kongens Lyngby (Denmark), Series A | Provider of scalable robotic platform | $29.2M | 49/100 | |
6th | Provider of robotic solutions for industrial laboratory automation | $427M | 47/100 | ||
7th | Andrew Alliance 2011, Vernier (Switzerland), Acquired | Provider of automated liquid handling tools and software for scientific labs | $14M | 45/100 | |
8th | Chemspeed 1997, Fullinsdorf (Switzerland), Acquired | Designer and manufacturer of lab instruments and consumables for R&D industries | - | 44/100 | |
9th | Protedyne 2000, Windsor Locks (United States), Acquired | Develops robotic platform for laboratory automation | $22M | 43/100 | |
10th | Flow Robotics 2015, Copenhagen (Denmark), Series A | Provider of an AI-based laboratory automation robot system for liquid handling | $17.1M | 42/100 |
Looking for more details on Reshape Biotech's competitors? Click here to see the top ones
Reshape Biotech's Investments and acquisitions
Reshape Biotech has made no investments or acquisitions yet.
News related to Reshape Biotech
Media has covered Reshape Biotech for 1 event in last 1 year.
•
Decoding VC Entrepreneurship: Understanding the Major Investor FamiliesFrenchWeb•Sep 08, 2025•Reddit, First AML, Reshape Biotech, Atomico and 18 others
•
•
•
•
Bio-Software Company Reshape picks up three-digit million amountsITWatch•Apr 10, 2024•Reshape Biotech, Astanor, R7 Partners, ACME and 3 others
•
Reshape Bio Raises $8.1M in FundingFinSMEs•Feb 09, 2023•FundersClub, Reshape Biotech, ACME, Y Combinator and 1 other
Are you a Founder ?
FAQs about Reshape Biotech
Explore our recently published companies
- Backchat Media - Tauranga based, 2014 founded, Acquired company
- Growzle - London based, 2025 founded, Unfunded company
- X-AVA - United States based, 2021 founded, Unfunded company
- Uresco Construction Materials - Kent based, 1979 founded, Unfunded company
- Aaa Flat Rate Moving - Sarasota based, 1980 founded, Unfunded company
- Walzak Marketing - Milwaukee based, 1980 founded, Unfunded company